Clinical Trial Update: Vedolizumab for Immune Mediated Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for vedolizumab in immune mediated colitis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune-mediated Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: University of Copenhagen | Conditions: Immune-Mediated Colitis | Phase 2 | Status: UNKNOWN